Data / Drug companies / Mission Pharmacal Company
Mission Pharmacal Company: 28 products in the FDA NDC directory, labeler code 0178
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Mission Pharmacal Company (labeler code 0178) lists 28 products in the FDA National Drug Code Directory, covering 11 finished drugs by generic name. By type: 24 prescription drugs, 4 over the counter drugs. Its main marketing category is other unapproved drugs. The newest product started marketing on October 26, 2026.
The request: Watch Mission Pharmacal Company (FDA labeler code 0178): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 0178
- Products in commercial distribution
- 28
- Packages
- 32
- Finished drugs by generic name
- 11
- Prescription products
- 24
- Over the counter products
- 4
- Flagged as original packager
- 25 of 25 products that carry the flag
- Started marketing in the last 12 months
- 1
- Products with a marketing end date set
- 1
- Earliest marketing start
- January 1, 1981
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Other unapproved drugs | 15 | 53.6% |
| New drug applications (NDA) | 8 | 28.6% |
| Over the counter monograph drugs | 3 | 10.7% |
| Generic drugs (ANDA) | 2 | 7.1% |
Products by type
| Type | Products | Share |
|---|---|---|
| Prescription drugs | 24 | 85.7% |
| Over the counter drugs | 4 | 14.3% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Sulfacetamide sodium, sulfur | 5 | 13 |
| Sulfacetamide sodium | 5 | 13 |
| Tiopronin | 3 | 8 |
| Methyl salicylate | 2 | 24 |
| Tinidazole | 2 | 7 |
| Potassium citrate | 2 | 17 |
| Acetohydroxamic acid | 1 | 1 |
| Sodium sulfacetamide | 1 | 10 |
| Potassium iodide | 1 | 10 |
| Zinc oxide | 1 | 595 |
| Hydrocortisone | 1 | 171 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Cream | 6 | 21.4% |
| Liquid | 3 | 10.7% |
| Tablet, film coated | 3 | 10.7% |
| Emulsion | 2 | 7.1% |
| Tablet, delayed release | 2 | 7.1% |
| Tablet | 2 | 7.1% |
| Solution | 2 | 7.1% |
| Tablet, extended release | 2 | 7.1% |
| Tablet, coated | 1 | 3.6% |
| Kit | 1 | 3.6% |
| Shampoo | 1 | 3.6% |
| Ointment | 1 | 3.6% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Theragesic | 0178-0320 | Cream | Over the counter monograph drugs | October 26, 2026 |
| Uribel tabs | 0178-0745 | Tablet, coated | Other unapproved drugs | November 7, 2023 |
| Thiola EC | 0178-0902 | Tablet, delayed release | New drug applications (NDA) | June 28, 2019 |
| Thiola EC | 0178-0901 | Tablet, delayed release | New drug applications (NDA) | June 28, 2019 |
| Potassium iodide | 0178-0314 | Solution | Generic drugs (ANDA) | May 15, 2016 |
| CitraNatal Assure | 0178-0891 | Kit | Other unapproved drugs | April 30, 2014 |
| CitraNatal 90 DHA | 0178-0821 | Tablet | Other unapproved drugs | April 11, 2014 |
| Texacort | 0178-0455 | Solution | Generic drugs (ANDA) | December 15, 2011 |
| Ovace Plus | 0178-0620 | Lotion | Other unapproved drugs | September 15, 2011 |
| Ovace | 0178-0499 | Liquid | Other unapproved drugs | September 15, 2011 |
| OvacePlus Plus | 0178-0495 | Cream | Other unapproved drugs | September 15, 2011 |
| OVACE Plus | 0178-0490 | Liquid | Other unapproved drugs | September 15, 2011 |
| OVACE Plus | 0178-0485 | Shampoo | Other unapproved drugs | September 15, 2011 |
| Avar | 0178-0480 | Emulsion | Other unapproved drugs | September 15, 2011 |
| Avar ls | 0178-0475 | Emulsion | Other unapproved drugs | September 15, 2011 |
| Avar-e | 0178-0470 | Cream | Other unapproved drugs | September 15, 2011 |
| Avar-e LS | 0178-0465 | Cream | Other unapproved drugs | September 15, 2011 |
| Avar-e Green | 0178-0460 | Cream | Other unapproved drugs | September 15, 2011 |
| Ovace plus | 0178-0630 | Liquid | Other unapproved drugs | September 7, 2011 |
| Dr smiths diaper | 0178-0330 | Ointment | Over the counter monograph drugs | March 1, 2010 |
| Ferralet 90 | 0178-0089 | Tablet, film coated | Other unapproved drugs | February 4, 2010 |
| Urocit-k | 0178-0615 | Tablet, extended release | New drug applications (NDA) | January 27, 2010 |
| Tindamax | 0178-8500 | Tablet, film coated | New drug applications (NDA) | May 17, 2004 |
| Tindamax | 0178-8250 | Tablet, film coated | New drug applications (NDA) | May 17, 2004 |
| Urocit-k | 0178-0610 | Tablet, extended release | New drug applications (NDA) | September 1, 1992 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.